External validation and extension of the TIMI risk score for heart failure in diabetes for patients with recent acute coronary syndrome: An analysis of the EXAMINE trial.

Amir Razaghizad Abhinav SharmaJiayi NiJoao Pedro FerreiraWilliam B WhiteCyrus R MehtaGeorge L BakrisFaiez Zannad

Published in: Diabetes, obesity & metabolism (2022)

with the extension of NT-ProBNP improves risk stratification and generalizes the use of the risk score for patients with T2D and ACS. Future validation studies in ACS populations may be warranted.

Keyphrases

acute coronary syndrome
heart failure
percutaneous coronary intervention
antiplatelet therapy
type diabetes
cardiovascular disease
clinical trial
study protocol
left ventricular
current status
glycemic control
atrial fibrillation
case control
metabolic syndrome
acute heart failure
genetic diversity
weight loss